The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.

The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...

In this opinion piece, former Democratic National Committee chairperson Howard Dean urges Democrats in Congress to help lower ...

Caremark'sundefined board rejected an unsolicited cash-and-stock bid from rival Express Scripts (ESRX) and reiterated its support for a planned deal with big drug store chain CVS (CVS) . Nashville ...

If I'm right, Express Scripts is the better stock to buy right now, even though I think CVS Health has the better long-term prospects. However, I'm not certain the Cigna buyout of Express Scripts ...

CVS CEO Larry Menlo said the company will make $300 million this year, and Cigna disclosed that Express Scripts makes $400 million. CVS, Express Scripts provide a rare moment of transparency on ...

Express Scripts has substantially outperformed CVS over the past 25 years. CVS has outperformed Express Scripts over the past 5 years. As a long term investment, I have a slight preference for ...

Few industries have the type of tailwinds in their favor that healthcare enjoys. With a large population of baby boomers entering their golden years.

CVS Health Corp. will make a new class of injectable cholesterol treatments its next major target in the fight against high drug costs. They may also cost $7,000 to $12,000 a year, and patients ...

It's been a tough year for investors who began 2017 holding shares of either CVS Health Corp. (NYSE: CVS) or Express Scripts Holding Company (NASDAQ: ESRX). Both stocks have fallen ...

Express Scripts trades at only 10 times forward earnings, while CVS Health trades at more than 13 times forward earnings. When growth potential is factored in, that gives Express Scripts an even ...